Geron Ends Phase 3 Rytelo Study in Myelofibrosis for Futility
Geron said an independent data monitoring committee advised ending the late-stage study because it was likely to fail.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.